ViewRay Systems(OTC) VRAYQ

Market Cap$200.00

Since IPO (2015)-100%

5 Year-100%

1 Year-90%

1 Month+0%

$0.00

+0.00%

+0.00Today

ViewRay Systems last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-09-04

ViewRay Systems stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-08-28
1 month	+0%	USD 0.00	2026-08-05
3 month	+0%	USD 0.00	2026-06-05
Year to date	+0%	USD 0.00	2025-12-31
1 year	-90%	USD 0.00	2025-09-04
3 year	-99.99%	USD 0.02	2023-09-05
5 year	-100%	USD 5.94	2021-09-03
Since inception	-100%	USD 5.00	2015-08-10

ViewRay Systems Financials at a Glance

Market Cap

$200.00

Revenue (TTM)

$105.86M

Net Income (TTM)

-$110.42M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-82.73 (Low)

Dividend

$0.00

Beta (Volatility)

-82.73 (Low)

Price

$0.00

Volume

4,052

Open

$0.00

Price

$0.00

Volume

4,052

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 31, 2026

Dividend

$0.00

Beta (Volatility)

-82.73 (Low)

Price

$0.00

Volume

4,052

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 31, 2026

VRAYQ News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ViewRay Systems

ViewRay, Inc. is a medical device company specializing in the design, manufacture, and marketing of MRI-guided radiation therapy systems. The company's flagship product, the MRIdian A3i, offers real-time 3D tissue tracking and automated beam control for cancer treatment.

Products and Services

MRIdian A3i: MRI-guided radiation therapy system
Real-time 3D tissue tracking technology
Automated beam control for precise treatment

Growth Outlook

Market demand for advanced cancer treatment technologies is increasing
Potential for expansion in international markets
Focus on innovation may lead to new product developments

Financial Highlights

Q1 2023 revenue of $22.5 million, down from $34.7 million in Q4 2022
Net income for Q1 2023 was -$28.9 million, reflecting ongoing operational challenges
Cash and cash equivalents at $81.3 million as of March 31, 2023

ViewRay, Inc. operates in a challenging environment, having recently transitioned from Chapter 11 to Chapter 7 bankruptcy. Despite these difficulties, the company continues to focus on its innovative MRI-guided radiation therapy systems, which are crucial for treating various types of cancer. The recent quarterly financials indicate a decline in revenue, highlighting the need for strategic adjustments. However, the significant cash reserves may provide a buffer for future operations and potential recovery efforts. The growing market for advanced cancer treatment technologies presents opportunities for ViewRay, should it successfully navigate its current challenges.

AI Generated • Aug 31, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

295

CEO

Scott William Drake

Website

www.viewray.com

Headquarters

Oakwood Village, OH 44146, US

VRAYQ Financials

Key Financial Metrics (TTM)

Gross Margin

9.83%

Operating Margin

-104.81%

Net Income Margin

-105.01%

Return on Equity

-85.17%

Return on Capital

-63.52%

Return on Assets

-39.55%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00

Shares Outstanding

183.40M

Volume

4.05K

Avg. Volume

6.72K

Financials (TTM)

Gross Profit

$8.52M

Operating Income

-$109.28M

EBITDA

-$99.06M

Operating Cash Flow

-$112.92M

Capital Expenditure

-$3.86M

Free Cash Flow

-$116.78M

Cash & ST Invst.

$81.29M

Total Debt

$85.13M

ViewRay Systems Performance Analysis

ViewRay Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 70,119,000	N/A
2022	2022-12-31	USD 102,206,000	45.8%

ViewRay Systems sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2022-06-30	17.3%
Q3	2022-09-30	19.6%
Q4	2022-12-31	31.0%
Q1	2023-03-31	-35.0%

ViewRay Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -0.67	N/A
2022	2022-12-31	USD -0.59	-11.2%

ViewRay Systems sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2022-06-30	-7.1%
Q3	2022-09-30	6.7%
Q4	2022-12-31	-7.1%
Q1	2023-03-31	-6.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2023YOY CHG

Revenue

$22.53M

+19.4%

Gross Profit

-$1.43M

-1621.3%

Gross Margin

-6.35%

N/A

Market Cap

$200.00

N/A

Market Cap/Employee

$0.68

N/A

Employees

295

N/A

Net Income

-$28.86M

-12.0%

EBITDA

-$25.25M

-7.7%

Quarterly Fundamentals

Name

Q1 2023YOY CHG

Total Cash

$81.29M

-54.9%

Total Debt

$85.13M

+26.4%

Accounts Receivable

$47.53M

+69.7%

Inventory

$42.19M

+61.8%

Long Term Debt

$4.44M

-92.2%

Short Term Debt

$80.69M

+654.9%

Return on Assets

-39.55%

N/A

Return on Invested Capital

-61.28%

N/A

Free Cash Flow

-$54.78M

-63.0%

Operating Cash Flow

-$53.60M

-65.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HTGMQHTG Molecular Diagnostics, Inc.

HTGMQHTG Molecular Diagnostics, Inc.$0.00+0.00%

NUWENuwellis, Inc.

NUWENuwellis, Inc.$0.78+6.29%

AEMDAethlon Medical, Inc.

AEMDAethlon Medical, Inc.$1.82-5.70%

WOKWORK Medical Technology Group Ltd. Class A

WOKWORK Medical Technology Group Ltd. Class A$2.10+1.45%

MODDModular Medical, Inc.

MODDModular Medical, Inc.$3.68+7.60%

VPT.VVentriPoint Diagnostics Ltd.

VPT.VVentriPoint Diagnostics Ltd.CA$0.10+5.56%

OMOutset Medical, Inc.

OMOutset Medical, Inc.$3.59+0.70%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.15-0.12%

NVDANvidia

NVDANvidia$230.36+0.01%

PATHUiPath

PATHUiPath$15.19-0.17%

INTCIntel

INTCIntel$95.80+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.13+0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.74-0.02%

TSLATesla

TSLATesla$354.08-0.06%

Questions About VRAYQ

What is the current price of ViewRay Systems?

ViewRay Systems is trading at $0.00 per share.

What is the 52-week range for ViewRay Systems?

Over the past 52 weeks, ViewRay Systems has traded between $0.00 and $0.00.

How much debt does ViewRay Systems have?

As of the most recent reporting period, ViewRay Systems reported total debt of $86.40M.

How much cash does ViewRay Systems have on hand?

ViewRay Systems reported $135.96M in cash and cash equivalents in its most recent financial results.

What is ViewRay Systems’s dividend yield?

ViewRay Systems does not currently have a dividend yield.

ViewRay Systems(OTC) VRAYQ

ViewRay Systems Financials at a Glance

VRAYQ News

Why ViewRay Stock Is Sinking Today

Why ViewRay Crushed the Market on Thursday

Why ViewRay Stock Vaulted Higher Today

Why ViewRay Stock Got Crushed Today

Why ViewRay Stock Dropped Today

Why ViewRay Stock Is Tanking Today

Why Lands' End, Audentes Therapeutics, and ViewRay Jumped Today

Why ViewRay Stock Is Shooting Higher Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ViewRay Systems

VRAYQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ViewRay Systems Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VRAYQ

What is the current price of ViewRay Systems?

What is the 52-week range for ViewRay Systems?

How much debt does ViewRay Systems have?

How much cash does ViewRay Systems have on hand?

What is ViewRay Systems’s dividend yield?

Premium Investing Services